Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Parker, Alex
REBIRTH, NCT05180773: Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy	Recruiting	4	250	US	Bromocriptine, Parlodel, Cycloset, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT), Rivaroxaban, Xarelto, Second Placebo	Dennis M. McNamara, MD, MS, National Heart, Lung, and Blood Institute (NHLBI)	Peripartum Cardiomyopathy, Postpartum	06/26	12/28
VOID-HF, NCT04227977: Volume Optimization Incorporating Negative Pressure Diuresis in Heart Failure	Completed	N/A	8	US	JuxtaFlow System	3ive Labs	Cardiorenal Syndrome	05/23	10/23
PROBIO_HA114, NCT06051123: Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients	Recruiting	N/A	150	Canada	Probiotic, Placebo	Centre hospitalier de l'Université de Montréal (CHUM), Lallemand Health Solutions	ALSFTD	02/27	02/27
Clark, Shaunmonique
REBIRTH, NCT05180773: Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy	Recruiting	4	250	US	Bromocriptine, Parlodel, Cycloset, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT), Rivaroxaban, Xarelto, Second Placebo	Dennis M. McNamara, MD, MS, National Heart, Lung, and Blood Institute (NHLBI)	Peripartum Cardiomyopathy, Postpartum	06/26	12/28
DEFINE AFib, NCT04926857: (Atrial Fibrillation)	Completed	N/A	973	US	Non-Interventional	Medtronic Cardiac Rhythm and Heart Failure	Atrial Fibrillation	01/24	01/24
Murphey, Jessica
REBIRTH, NCT05180773: Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy	Recruiting	4	250	US	Bromocriptine, Parlodel, Cycloset, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT), Rivaroxaban, Xarelto, Second Placebo	Dennis M. McNamara, MD, MS, National Heart, Lung, and Blood Institute (NHLBI)	Peripartum Cardiomyopathy, Postpartum	06/26	12/28